Two cases of carfilzomib ‐induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma

Treatment with proteasome inhibitors like carfilzomib in patients with multiple myeloma (MM) can induce thrombotic microangiopathy (TMA) characterized by neurological symptoms, acute kidney injury, hemolysis a...
Source: BMC Nephrology - Category: Urology & Nephrology Authors: Tags: Case report Source Type: research